Abstract. In Xenopus oocytes, the mos protooncogene product is required during meiosis I for the activation of maturation promoting factor (MPF) and the subsequent breakdown of the germinal vesicle (GVBD) . In addition, the mos product has been shown to be a candidate "initiator" of meiotic maturation and is an active component of cytostatic factor (CSF), an activity responsible for metaphase II arrest. Here we demonstrate that pp39mos is required throughout oocyte maturation . We found that in progesterone stimulated oocytes, depletion of mos RNA immediately before GVBD terminally decreased MPF. Likewise, oocytes depleted of mos RNA and induced to mature with crude MPF proceeded through GVBD, but lacked the
oncogene product is required during meiosis I for the activation of maturation promoting factor (MPF) and the subsequent breakdown of the germinal vesicle (GVBD) . In addition, the mos product has been shown to be a candidate "initiator" of meiotic maturation and is an active component of cytostatic factor (CSF), an activity responsible for metaphase II arrest. Here we demonstrate that pp39mos is required throughout oocyte maturation . We found that in progesterone stimulated oocytes, depletion of mos RNA immediately before GVBD terminally decreased MPF. Likewise, oocytes depleted of mos RNA and induced to mature with crude MPF proceeded through GVBD, but lacked the F UI.I .Y grown Xenopus oocytes arrested in prophase of meiosis I (Masui and Clarke, 1979) are induced to mature with progesterone, resulting in the activation of maturation promoting factor (MPF)' and the progression through meiosis (Masui and Markert, 1971; Ford, 1985) . MPF is a cytoplasmic protein kinase activity that leads to nuclear envelope breakdown as well as chromosome condensation (Miake-Lye et al., 1983; Maller, 1985) and consists of two proteins, the homologue of the p34c&z protein from Schizosaccharomyces pombe (Gautier et al ., 1988; Dunphy et al., 1988 ) and a cyclin protein (Draetta et al., 1989 ; Meijer et al ., 1989; Pines and Hunter, 1989; Gautier et al., 1990) . Progesterone treatment of Xenopus oocytes rapidly induces the synthesis of the mos proto-oncogene product, pp39m°s, that precedes MPF activation and germinal vesicle breakdown (GVBD) (Sagata et al ., 19ß9a) . Moreover, the introduction of c-mosxe RNA into fully grown oocytes triggers the activation of MPF and GVBD (Sagata et al., 19ß9a ; Freeman et al., 1989) .
In Xenopus oocytes, pp39mo , is required for MPF activation and GVBD induced by progesterone (Sagata et al., 1988 ; Barrett et al., 1990) , while in mouse oocytes, R . S . Paules' present address is Mammalian Molecular Genetics Group, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709.
1 . Abbreviations used in this paper : CSF, cytostatic factor ; GVBD, germinal vesicle breakdown ; MPF, maturation promoting factor. 0 The Rockefeller University Press, 0021-9525/91/07/329/7 $2 .00 The Journal of Cell Biology, Volume 114, Number 2, July 1991 329-335 MPF activity required to arrest mature oocytes at metaphase II . Thus, during maturation the mos product is required, directly or indirectly, to sustain MPF activity. On the other hand, mouse NIH/3T3 cells transformed by the constitutive expression of pp39mo ,-possessed CSF activity but lacked constitutive levels of MPF or its associated histone HI kinase activity. Moreover, cytosols prepared from transformed NIH/ 3T3 cells or Xenopus eggs had similar levels of CSF activity, but pp39mo5 levels were >40-fold higher in the transformed cell extract. These analyses show that maintenance of CSF during interphase does not result in the maintenance of MPF.
pp39m ,, is required only after GVBD (O'Keefe et al., 1989 ; Paules et al., 1989) . Moreover, the mos product is expressed throughout maturation in both Xenopus and mouse oocytes undergoing maturation (Sagata et al., 1988; Watanabe et al., 1989; Paules et al., 1989) . The above evidence suggests that pp39m°s function is required throughout meiotic maturation (Paules et al., 1989) . Recently, pp39mos has been identified as an active component of cytostatic factor (CSF) (Sagata et al., 19ß9b) , a calcium-sensitive activity believed to be responsible for the arrest ofan unfertilized egg at metaphase II and for the stabilization ofMPF (Masui and Clarke, 1979; Newport and Kirschner, 1984; Sagata et al., 19ß9b ; Murray et al., 1989 ) . Here we provide evidence that the mos product is required throughout meiotic maturation for the maintenance of MPF In contrast, we show that CSF activity is present in c-mos-transformed mouse NIH/3T3 cells during interphase, while MPF activity is not.
Materials and Methods
Frogs, Oocytes, Eggs, and Embryos
Xenopus laevis females were purchased from Xenopus I (Ann Arbor, MI) . Oocytes were surgically removed and defolliculated by incubation in modified Barth solution (MBS ; 88 mM NaCl, 1 mM KCI, 2 .4 mM NaHC03, 10 mM Hepes [pH 7.5], 0.82 mM MgSO4, 0.33 mM Ca(N03)2, 0.41 mM CaCl2) containing collagenase A (Boehringer Mannheim Biochemicals, Indianapolis, IN) (2 mg/ml) for 2 h (Gurdon and Wickens, 1983) . The oocytes were washed in MBS several times before the stage VI 329 (Dumont, 1972) oocytes were isolated . To obtain eggs, frogs were injected with 100 IU of pregnant mare serum gonadotropin 72 h before an injection of 625 IU of human chorionic gonadropin into the dorsal lymph sac . Frogs were maintained 12-14 h in lx MMR (0.1 M NaCl, 2 mM KCI, 1 mM MgCl2, 2 mM CaC12, 0.1 mM EDTA, 5 mM Hepes [pH 7.8]) at 18°C, and the laid eggs were transferred to a 100-mM dish containing 1 x MMR .
To obtain embryos, eggs were placed in 100% Ringers' solution (0.1 M NaCl, 1 .8 mM KCI, 1 MM MgCl2, 2 mM CaC12, 4 mM NaHC03) . Minced testes were added to the dish containing the eggs, and 2 vol of H2O were added to dilute the Ringers' solution to 0.3 x . After 15 min, eggs were dejellied in 0.3X MMR containing 2 % cysteine (pH 7.9) . The eggs were washed several times with 0 .3 x MMR and cultured in 0.3 x MMR containing 5 % Ficoll 400 .
Oligodeoxyribonucleotide Injections 18 h after fully grown oocytes were isolated, microinjections were performed with 40 nl of a mixture of either antisense or sense mos-specific oligodeoxyribonucleotides (oligonucleotides ; 3 mg/ml), denoted by At, Bt, Ct, Dt as described by Sagata et al . (1988) . Subsequent injections of crude MPF were performed 4 h later .
MPFAssay
Crude MPF extracts were prepared by homogenizing groups of 10-20 oocytes or embryos in 20-40 Al of extraction buffer (80 mM sodium 0-glycerophosphate, 20 mM EGTA, 15 MM M9C12, 20 mM Hepes [pH 7.2], 1 mM ATP, 1 mM DTT, 5 mM NaF) . The homogenate was centrifuged at 16,000 g for 5 min at 4°C, and the supernatant was used for microinjections . Groups of 12-14 oocytes were incubated in Ix MBS containing cycloheximide (10 pg/ml) for 1 h and then injected with 40 nl of the supernatant from each appropriate donor group . The recipient oocytes were cultured 3-4 h in the presence of cycloheximide, then examined for GVBD. GVBD was scored by the observation of a white spot at the animal pole. The oocytes were fixed in 10% TCA for 10 min, then dissected and examined under a binocular microscope for the presence or absence of the germinal vesicle .
CSF Assay
Either eggs or NIH/3T3 cells expressing tpr-met, ras, or Xenopus mos were washed with CSF extraction buffer (0.25 M sucrose, 0.2 M NaCl, 5 mM MgSO4, 2 .5 mM EGTA, 20 mM Hepes [pH 6.5], 10 mM NaF, 80 mM sodium ß-glycerophosphate, 2 mM DTT, 6 mM ATP) . The CSF extraction buffer was removed, and the samples were crushed at 100,000 g at 2°C for 1 .5 h . The supernatant was removed and 40 nl was injected into either one or both blastomeres of a 2-cell embryo . The embryos were maintained in 0.3 x MMR containing 5 % Ficoll 400 for 4-6 h and examined for cleavage .
Histone HI Kinase Assay 2 At of extract was transferred into 50 At of extraction buffer (80 mM sodium 0-glycerophosphate, 20 mM EGTA, 50 MM M9C12, 20 mM Hepes [pH 7.2], 1 mM DTT, 2 .5 mM PMSF, 10 pg/ml leupeptin, 10 Ag/ml aprotinin, 10 AM protein kinase inhibitor) . The histone Hl kinase reaction was performed by adding 10 Al pf the sample to 6 AI of a mixture containing 1 pg/Al histone Hl, 1 mM ATP, and 1 ACi [ , y32 P]ATP. The reaction was incubated at room temperature for 15 min and then stopped by the addition of an equal volume of 2x sample buffer (4% SDS, 20% glycerol, 150 mM Tris-HCI [pH 6.8], 0.02 % bromophenol blue, 5 % 0-mercaptoethanol) . Samples were resolved by SDS-PAGE on a 12% gel . Gels were fixed in 40% methanol, 5 % acetic acid, then dried, and exposed to film .
Immunoprecipitation and Western BlottingAnalysis
From either 300 Xenopus eggs or 4 x 10 1 c-mos`°-transformed NIH/3T3 cells or nontransformed NIH/3T3 cells, a CSF extract was prepared as described above. To 100 WI of each extract, an equal amount of 2 x RIPA buffer plus protease inhibitors (2 .0% NP-40, 1 .0% sodium deoxycholate, 0.2% SDS in PBS plus 5 .0 mM PMSF and 120 kallikrein inhibitor units of aprotinin per milliliter) was added. These samples were subjected to immunoprecipitation with the 5S monoclonal Xenopus mos antibody as described (Sagata et al ., 19ß9a) . Immune complexes were resolved by 3-17 % gradient SDS-PAGE . Western transfer was performed as described (Burnette, 1981) . pp39m°' was detected with 5S monoclonal antibody and alkaline phosphatase-conjugated goat anti-mouse IgG.
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Immunoprecipitation and In Vitro Kinase Assay
To 100 A1 of CSF extract, 5S monoclonal antibody (Sagata et al ., 19ß9a) was added, incubated for 3 h, and complexed with 10% protein A-Sepharose in CSF buffer. The pellet was washed five times in wash buffer (1% NP-40, 150 mM NaCl, 1 mM EDTA, 10 mM sodium phosphate, 20 AM leupeptin, 2 mM PMSF, 10 AM pepstatin, 2 mM dithiothreitol, 120 kallikrein inhibitor units of aprotinin per milliliter) . Then 50 AI of solution A (0 .1% NP-40,150 mM NaCl, 10 mM sodium phosphate [pH 7.2], 2 mM DTT, 1 mM sodium pyrophosphate) and 5 Al of 2 mM quercitin (Sigma Chemical Co., St . Louis, MO) was added to the immune complex and incubated on ice for 10 min. After the addition of 50 At of solution B (0.1% NP-40, 150 mM NaCl, 10 mM sodium phosphate [pH 7.2], 2 mM DTT, 1 mM sodium pyrophosphate, 15 mM MnC12, 20 AM ATP, 50 ACi of [ ,y32 P]ATP) the reaction mix was incubated at room temperature for 10 min . 2 x sample buffer was added, and the sample was resolved on a 12 % SDS-polyacrylamide gel . Gels were fixed, dried, and exposed to film .
Cell Culture NIH/3T3 cells transformed by the Xenopus mos product expressed from a plasmid containing the Xenopus mos gene (Sagata et al ., 1988 ) just downstream of a Moloney sarcoma virus long terminal repeat (Yew et al ., 1991) were cultured in DMEM containing 8% calf serum. NIH/3T3 cells transformed by either the activated H-ras oncogene (gift from Dr. Youyong Lu) or the tpr-met oncogene (Park et al ., 1986) were also cultured in DMEM with 8 % calf serum . Mitotic cell cycle arrest was achieved by the addition of medium containing 0.4 mg/ml of nocodozole (Calbiochem-Behring Corp., Palo Alto, CA) and incubating the cell culture 7.5-20 h at 37°C. Mitotic cells were collected by shaking off the loosely attached cells and centrifugation at 1,500 g for 5 min . The mitotic index was determined to be -80% by light microscopy.
Results
Antisense Oligonucleotides Inhibit MPF Activation after GVBD
The induction of MPF and GVBD by progesterone or insulin is blocked by the injection of mos-specific antisense oligonucleotides (Sagata et al., 1988) . To examine whether pp39m°' synthesis is required after GVBD, fully grown stage VI oocytes were microinjected with a mixture of either antisense or sense mos-specific oligonucleotides and subsequently injected with MPF to overcome the block to GVBD imposed by the depletion of pp39m°s . Oocytes were cultured 8 h following GVBD to allow for progression through meiosis I and arrest at metaphase II (Gerhart et al., 1984) . Cytosolic ex- Donor Recipient * 8 h after GVBD, cytosolic extracts were prepared from oocytes that had been injected with crude MPF extracts subsequent to either mos sense or antisense oligonucleotide injection as described in Materials and Methods . These donor extracts were injected into recipient cycloheximide-treated (10 /4g/ml) oocytes and scored for GVBD as described in Materials and Methods . t 8 h after GVBD, cytosolic extracts were prepared from oocytes that were treated with progesterone and subsequently injected with either sense or antisense mos oligonucleotides as described in Materials and Methods . These donor extracts were injected into recipient cycloheximide-treated (10 hg/ml) oocytes and scored for GVBD as described in Materials and Methods. tracts were then prepared and tested for MPF activity by microinjection into cycloheximide-treated fully grown oocytes (Table I) . MPF can induce GVBD even in the presence of cycloheximide (Wasserman and Masui, 1975 ; Cyert and Kirschner, 1988) . Our experiments showed that mos RNA depletion prevented the appearance of MPF 8 h after GVBD (Table I) . Moreover, there was a 50% increase in the time required to reach GVBD in the mos RNA depleted oocytes (data not shown) . These analyses demonstrated that mos was required after GVBD, even in the presence of injected MPF, and MPF-induced GVBD was accelerated in the presence of endogenous pp39m°, . We tested whether pp39m°, synthesized before GVBD, was sufficient to allow progression through later stages of meiosis . Fully grown oocytes were treated with progesterone (5 FtM) for 3 h, a time where GVBD had occurred in -20% of the oocytes, and a time when substantial mos protein synthesis has occurred (Sagata et al., 1989a ; Watanabe et al., 1989 ; data not shown) . Oocytes not displaying GVBD at 3 h were injected with either sense or antisense mos-specific oligonucleotides . Under these conditions, GVBD was not blocked by mos antisense oligonucleotides (Table I) . Oocytes were cultured for an additional 8 h to allow progression to metaphase II (Gerhart et al ., 1984) . When these oocytes Daar were tested for MPF activity, none was found in the oocytes depleted of mos RNA (Table I) . Collectively, these results and previous findings (Sagata et al., 1988 (Sagata et al., , 1989a Freeman et al ., 1989 ; Barrett et al., 1990; Paules et al., 1989) show that de novo synthesis of endogenous pp39m o5 is required after GVBD for mouse or Xenopus oocyte maturation and is required for the appearance and/or stabilization of MPF at metaphase II .
The previous experiments showed that pp39m°, synthesis was required after GVBD for the maintenance of MPR It was formally possible that the maturing oocytes entered the second meiosis with an accompanying rise in MPF, only to have MPF levels fall as a function of time in the absence of mos . To determine whether the second rise in MPF occurred, oocytes undergoing GVBD after 4 h of progesterone treatment were injected with either sense or antisense mos oligonucleotides and crude MPF extracts were prepared at half hour intervals. These extracts were then tested for MPF activity and histone Hl kinase activity (Fig . 1) . These analyses demonstrate that MPF and histone Hl kinase activities terminally decrease within the first half hour after mos antisense oligonucleotides were injected (Fig . 1) , while sense oligonucleotide injected oocytes showed typical cycling of MPF and histone Hl kinase activity. These data show that pp39m°, synthesis Figure 2 . Kinetics of pp39mo5 proteolytic degradation after either antisense oligonucleotide injection or cycloheximide treatment of oocytes . Stage VI oocytes were continuously labeled during progesterone treatment . After 3 h, oocytes were either injected with antisense oligonucleotides or treated with cycloheximide (10 pg/ ml) . At the indicated times, groups of 50 oocytes were homogenized in RIPA buffer and immunoprecipitation analysis was performed .
is required for the stabilization of MPF at metaphase I as well as the induction of MPF at metaphase II . To prove that pp39m ,, was lost after antisense oligonucleotide treatment, as suggested in previous studies with cycloheximide (Watanabe et al., 1989) , we continuously labeled oocytes for 3 h in the presence of progesterone before microinjection with antisense oligonucleotides or treatment of cycloheximide . These analyses show that with either treatment the mos product disappeared very rapidly (Fig. 2) .
Extractsfrom c-mos=e-transformed NIH/3T3 Cells Contain CSF, but Not MPF The mos product was required for MPF activity during meiotic maturation in oocytes . In mouse cells transformed by c-mos,° (Freeman et al ., 1989 ; Yew et al ., 1991) , mos is expressed constitutively, and it has been proposed that this may result in the stabilization of MPF during interphase (Sagata et al., 1989b) . We tested extracts prepared from NIH/3T3 cells transformed by the Xenopus mos product for CSF and MPF activity. Extracts microinjected into one blastomere of a 2-cell embryo prevented cleavage as did control CSF extract prepared from Xenopus eggs, while the uninjected blastomeres continued to cleave (Fig . 3 ) . In contrast, extracts prepared from nontransformed NIH/3T3 cells or NIH/3T3 cells transformed by other oncogenes (i .e ., the tyrosine kinase oncogene, tpr-met [Park et al ., 1986] were prepared and tested for histone Hl kinase activity. 30 nl of the extracts described in A and B were microinjected into fully grown oocytes maintained in MBS containing cycloheximide (10 ug/ml) as described in Materials and Methods . The number of oocytes that underwent GVBD within 3-h postinjection are indicated above the number of oocytes injected. These numbers are represented below the corresponding lanes in A and B.
H-ras°el'z) were unable to induce cleavage arrest when injected into embryos . Thus, extracts from somatic cells transformed by the Xenopus mos proto-oncogene product specifically induced an embryonic cleavage arrest that was not the result of an activity found in nontransformed NIH/3T3 cells or derivatives of these cells transformed by other oncogenes . CSF arrests embryonic cleavage at metaphase by preventing directly or indirectly the inactivation of MPF (Newport and Kirschner, 1984 ; Murray et al ., 1989 ; Sagata et al., 1989b) , and cleaving embryos arrested in metaphase by extracts from c-more-transformed cells, like embryos arrested by authentic egg CSF, were positive for MPF activity (data not shown) . The previous experiments demonstrated that CSF activity was present in c-mos ,°-transformed NIH/3T3 cell extracts. However, these same extracts were negative for MPF activity, while extracts prepared from either Xenopus eggs or mitotically arrested NIH/3T3 cells were positive for MPF (Fig . 4) . We also tested the c-mos,°-transformed cell extracts for MPF-associated histone Hl kinase activity (Fig. 4) and, while extracts from eggs and mitotic NIH/3T3 cells displayed high levels of this enzymatic activity, extracts from c-mostransformed cells were no higher in this activity than extracts prepared from interphase nontransformed NIH/3T3 cells (Fig . 4) . In addition, there was no evidence for the existence of an MPF inhibitory factor in c-mosxe-transformed cell extracts, since mixtures of this extract with a Xenopus egg extract were positive for both MPF and histone Hl kinase activity (Fig . 4) . Thus, CSF activity is present in interphase Xenopus mos-transformed cells, but MPF does not appear to be . We have not yet tested NIH/3T3 cells transformed with other mos genes .
The Levels of CSF Activity Are Similar in Eggs and mos,°-transformed Cells
The level of CSF activity observed in extracts from c-mosxe_ transformed cells was similar to the level found in an equal volume of extracts from unfertilized Xenopus eggs, i .e., the egg extract had slightly more activity at a 1 :1 dilution (Fig. 
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3) . The CSF activities were similar on a per unit volume basis even though the concentration of mos protein was 16 pg/ml in c-mos,°-transformed cell extracts and 40 ng/ml in egg extracts. We observed the same results when these extracts were diluted into cytosols prepared from either NIH/ 3T3 cells or from fully grown oocytes that lack mos (data not shown) . Thus, the difference in specific activity is not due to transacting inhibitors in the mouse cells or to an apparent need for limiting factors present in the oocyte . Surprisingly, Western analysis showed that there was at least 40 times more pp39m in the extract prepared from the asynchronous population of c-mos-transformed cells when compared to an equal volume of egg extract (Fig . 5 A) . These results revealed a dramatic variation in the ratio of CSF activity to pp39m°, . The observed differences in specific activity were apparently not due to M-phase, since extracts from cells treated with nocodozole for 7-20 h displayed only slightly more CSF activity than Xenopus egg extracts at a 1 :3 dilution (data not shown) .
A correlation has been established between in vitro autophosphorylation activity and biological activity of the mos proto-oncogene (Singh et al ., 1986 (Singh et al ., , 1988 Hannik and Donoghue, 1985 ; Yew et al., 1991) . We compared the relative in vitro autophosphorylation activity of the mos product immunoprecipitated from equal volumes of CSF extracts prepared from either unfertilized eggs or asynchronously growing c-mosxe-transformed NIH/3T3 cells . Despite the 40-fold excess of pp39m°, in the c-mosxe-transformed cell immune complex (Fig . 5 A) , we observed that pp39m°, autophosphorylation activity in this complex was significantly lower than the activity displayed from an equal volume of Xenopus egg extract (Fig . 5 B) . (The phosphorylated proteins observed in the 55-58-kD range are cx-and ß-tubulin that complex with and are substrates of pp39m°, in vitro and perhaps in vivo [Zhou et al ., 1991x, b] ) . Moreover, pp39m°5 autophosphorylation in immune complexes prepared from mitotic c-mosxe-transformed cells was only two-to five-fold higher than from asynchronous transformed cell populations (data not shown) . This is consistent with the increase in autokinase activity during M-phase recently reported for NIH/ 3T3 cells transformed by v-mos (Liu et al., 1990) . We conclude that the specific CSF or kinase activity of the Xenopus mos product produced in transformed mouse cells is only a fraction of the activity found in Xenopus eggs .
Discussion
In Xenopus, the mos proto-oncogene product is required for MPF activation prior to GVBD and is a component of CSF, an activity responsible for the stabilization of MPF at metaphase II (Sagata et al., 1988 (Sagata et al., , 1989b Watanabe et al ., 1989) . Metabolic labeling of oocytes shows that the mos product is present throughout maturation (Sagata et al ., 1988 ; Watanabe et al ., 1989) . We have shown that the mos product is necessary during Xenopus oocyte maturation before and after GVBD. We tested for pp39m°, function during meiosis using two approaches . The injection of crude MPF extracts into oocytes depleted of mos RNA allowed oocytes to advance through GVBD, albeit at a significantly slower rate than in the presence of endogenous pp39m°, . It is curious that MPF-injected oocytes treated with cycloheximide undergo GVBD within minutes of those competent for pro-tein synthesis (Gerhart et al., 1984) , while GVBD in mosdepleted oocytes takes 1 h longer. This could be explained by a requirement for de novo synthesis of an inhibitor of MPF during meiosis I, such as p40MO's, recently identified by Shuttleworth et al . (1990) . Most importantly, pp39mo , synthesis was required after GVBD for the reappearance of MPF activity later in maturation. It has previously been shown that after GVBD, protein synthesis is required for completion of meiosis I and the reappearance of MPF that accompanies meiosis II (Gerhart et al., 1984) . Thus far, the proteins that must be synthesized during this period have not been identified; for example, cyclin synthesis is not required for the first and second meiosis (Minshull, J., personal communication) . Our experiments show that mos protein is required after GVBD in Xenopus oocytes as well as before GVBD (Sagata et al., 1988) , and perhaps throughout meiosis since our experiments indicate that MPF and histone H1 kinase activities decrease precipitously in the presence of mos antisense oligonucleotides. We have also shown that the pp39mo , synthesized before GVBD does not eliminate the requirement for mos product synthesis after GVBD and is similar to results reported for mouse oocytes (Paules et al ., 1989; O'Keefe et al., 1989) . Our results as well as previous reports indicate that, directly or indirectly, CSF stabilizes MPF (Masui and Clarke, 1979 ; Newport and Kirschner, 1984; Murray et al., 1989; Sagata et al., 1989b) . Our experiments, however, do not distinguish between whether mos product is required for the formation of an active MPF, whether the MPF is unstable in the absence of mos product, or both.
Constitutive expression of the mos proto-oncogene product in somatic cells results in transformation (Oskarsson et al., 1980; Blair et al ., 1981) . We have postulated that expression of mos metaphase activity during interphase is responsible for the transformed phenotype . It has also been suggested that the transformed phenotype may be due to CSF stabilizing MPF during interphase. In this report, we demonstrated that CSF activity is present in c-more-transformed cells. However, we were unable to detect MPF or its associated histone H1 kinase activity in extracts prepared from an asynchronous population of the c-mos,°-transformed cells, while these activities were detected in mitotic cells . We conclude that the ratio of CSF to MPF in unfertilized eggs is not maintained in c-mos ,°-transformed cells, and the maintenance of significant levels of MPF in these cells is apparently not a component ofthe transformed phenotype . This is the first example of a biological system showing that CSF activity can exist during interphase and, more importantly, that this activity can persist during interphase and not sustain detectable levels of MPF. It is possible that mouse tissue culture cells may lack factors necessary for responding to CSF and that other products may perform a similar function during mitosis . We believe that the lack of mitotic arrest in mouse cells transformed by the Xenopus mos product is not due to species differences since the mouse mos product arrests embryonic cleavage as efficiently as the Xenopus mos product (Yew et al., 1991) . In addition, mouse cells can be efficiently transformed by the mouse mos product (Blair et al., 1981; Yew et al., 1991) . However, a question is raised regarding the major function ofCSF. CSF may stabilize MPF, but only during M-phase, indicating that MPF stability is a function of more than one factor and that CSF stabilization of MPF is not direct and may require the synthesis of other proteins. Consistent with this notion, extracts from c-mos,°-transformed cells which contain active pp39m°, do not induce GVBD in the absence of protein synthesis (data not shown) . However, this result could be due to the level ofmos product since more mos protein may be required to induce oocyte maturation than embryonic arrest (Sagata et al ., 1989x, Yew et al., 1991 .
The amount ofCSF activity per unit volume of cell extract was very similar in extracts prepared from either eggs or c-mos-transformed cells. At a 1:1 dilution, Xenopus egg extract induced embryonic arrest in approximately three-fold more embryos than that of c-mos,°cell extract and roughly correlates with the five-fold difference in autophosphorylation activity of mos product observed in these extracts. Surprisingly, there was a 40-fold excess of mos product present in the extract from c-mos,°-transformed cells . However, mos protein autophosphorylation is only slightly higher in immune complexes prepared from c-mos-transformed cells held in mitosis by nocodozole. Collectively, these results indicate that the mos product from transformed cells exhibits only -2 % of the activity found in the product from egg cytosol. CSF extracts diluted into extracts prepared from either NIH/3T3 cells or fully grown Xenopus oocytes showed no enhancement of CSF activity, indicating that there were no limiting amounts of enhancing factor(s) . Posttranslational modification such as phosphorylation could explain the differences in CSF and c-mos,°autokinase activity. Another possible explanation however, is that the amphibian mos product is less stable in mouse cells at 37°C. It is also possible that a nondissociating negative regulatory factor like tubulin oligomers (Zhou et al., 1991) associates with the mos product in NIH/3T3 cells, since mixtures of egg and transformed cell extracts showed no reduction in CSF activity (data not shown) .
How does a gene product that arrests embryonic cell cleavage transform somatic cells? It has been observed that cells acutely infected with the Moloney murine sarcoma virus express high levels of mos product, subsequently round up, and detach from the monolayer (Fischinger and Haapala, 1971 ; Papkoff et al ., 1982) . These infected cells express 30-to 100-fold higher levels of mos product than transformed cell populations (Papkoff et al., 1982) . The morphological alteration of mos-infected cells may be similar to that of mitotic rounding and might be an effect of CSF activity. We have proposed that the mos product may be responsible for the modification of tubulin and that mos, directly or indirectly, is an effector of the transformed phenotype (Zhou et al., 1991x, b) . We have postulated that the transformed phenotype may represent expression of mitotic events during interphase (Sagata etal ., 1988) and that selection for the transformed phenotype is a selection for cells expressing levels of pp39m°, sufficient for transformation but below the levels required for CSF arrest (Sagata et al ., 1989b) . The specific activity of the Xenopus pp39m°, is much lower in transformed mouse cells than in unfertilized eggs suggesting that in mouse cells CSF/mos function is attenuated. The mechanism of this attenuation may be equivalent to a tumor suppressor function .
